Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ZM-008 by Zumutor Biologics for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
ZM-008 is under clinical development by Zumutor Biologics and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to...
ZM-008 by Zumutor Biologics for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
ZM-008 is under clinical development by Zumutor Biologics and currently in Phase I for Head And Neck Squamous Cell Carcinoma...
ZM-008 by Zumutor Biologics for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval
ZM-008 is under clinical development by Zumutor Biologics and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer)....
ZM-008 by Zumutor Biologics for Non-Small Cell Lung Cancer: Likelihood of Approval
ZM-008 is under clinical development by Zumutor Biologics and currently in Phase I for Non-Small Cell Lung Cancer. According to...
ZM-008 by Zumutor Biologics for Glioblastoma Multiforme (GBM): Likelihood of Approval
ZM-008 is under clinical development by Zumutor Biologics and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...
ZM-008 by Zumutor Biologics for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
ZM-008 is under clinical development by Zumutor Biologics and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to...
ZM-008 by Zumutor Biologics for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
ZM-008 is under clinical development by Zumutor Biologics and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to...
ZM-008 by Zumutor Biologics for Colorectal Cancer: Likelihood of Approval
ZM-008 is under clinical development by Zumutor Biologics and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
ZM-008 by Zumutor Biologics for Prostate Cancer: Likelihood of Approval
ZM-008 is under clinical development by Zumutor Biologics and currently in Phase I for Prostate Cancer. According to GlobalData, Phase...
ZM-008 by Zumutor Biologics for Ovarian Cancer: Likelihood of Approval
ZM-008 is under clinical development by Zumutor Biologics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...